COA and Flatiron Health Study Finds Patients May Experience Longer Survival in Community Oncology Settings - Summary - MDSpire
Clinical Guidelines

COA and Flatiron Health Study Finds Patients May Experience Longer Survival in Community Oncology Settings

Share

A recent study by the Community Oncology Alliance (COA) found that patients with metastatic breast cancer and non-small cell lung cancer (NSCLC) experienced longer survival rates when treated at independent community oncology practices, compared to national averages. Specifically, breast cancer patients had an 8-month survival advantage and NSCLC patients had a 2-month advantage. The study underscores the quality of care provided in community settings and emphasizes the importance of provider partnerships in improving patient outcomes, as highlighted by Debra Patt, MD, PhD, and Stephen Divers, MD.

Original Source(s)

Related Content